Involvement of low- and middle-income countries in randomized controlled trial publications in oncology

[1] Mellstedt H(2006)Cancer initiatives in developing countries Ann Oncol 17 viii24-viii31

[2] Kanavos P(2006)The rising burden of cancer in the developing world Ann Oncol 17 viii15-viii23

[3] Hanna TP(2010)Cancer control in developing countries: using health data and health services research to measure and improve access, quality and efficiency BMC Int Health Hum Rights 10 24-713

[4] Kangolle AC(2010)Building research capacity and clinical trials in developing countries Lancet Oncol 11 712-823

[5] Arai RJ(2009)Ethical and scientific implications of the globalization of clinical research N Engl J Med 360 816-91

[6] Mano MS(2013)Geographic location of antineoplastic agent clinical trials conducted in developed and developing countries Int J Clin Pharm 35 87-432

[7] De Castro G(2012)The state of research and development in global cancer surgery Ann Surg 255 427-53

[8] Diz Mdel P(2006)Breast cancer in limited-resource countries: treatment and allocation of resources Breast J 12 S38-2677

[9] Hoff PM(2012)The geographical distribution of leadership in globalized clinical trials PLoS One 7 e45984-106

[10] Glickman SW(2006)Multinational clinical trials in oncology and post-trial benefits for host countries: where do we stand? Eur J Cancer 42 2675-900

[1] Mellstedt H(2006)Cancer initiatives in developing countries Ann Oncol 17 viii24-viii31

[2] Kanavos P(2006)The rising burden of cancer in the developing world Ann Oncol 17 viii15-viii23

[3] Hanna TP(2010)Cancer control in developing countries: using health data and health services research to measure and improve access, quality and efficiency BMC Int Health Hum Rights 10 24-713

[4] Kangolle AC(2010)Building research capacity and clinical trials in developing countries Lancet Oncol 11 712-823

[5] Arai RJ(2009)Ethical and scientific implications of the globalization of clinical research N Engl J Med 360 816-91

[6] Mano MS(2013)Geographic location of antineoplastic agent clinical trials conducted in developed and developing countries Int J Clin Pharm 35 87-432

[7] De Castro G(2012)The state of research and development in global cancer surgery Ann Surg 255 427-53

[8] Diz Mdel P(2006)Breast cancer in limited-resource countries: treatment and allocation of resources Breast J 12 S38-2677

[9] Hoff PM(2012)The geographical distribution of leadership in globalized clinical trials PLoS One 7 e45984-106

[10] Glickman SW(2006)Multinational clinical trials in oncology and post-trial benefits for host countries: where do we stand? Eur J Cancer 42 2675-900